Compare Manhattan Associates Inc (MANH) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs Novavax Inc — how do they compare? Manhattan Associates Inc trades at $159.61 (market cap $9.79B), while Novavax Inc trades at $8.08 (market cap $1.30B). The key difference: Manhattan Associates Inc is far larger — about 7.5× Novavax Inc's market cap. Which is the better fit depends on your goals.
| MANH | NVAX | |
|---|---|---|
Market Cap | $9.79B | $1.30B |
Sector | Technology | Health |
52-Week High | $227.94 | $11.19 |
52-Week Low | $120.88 | $6.22 |
Enterprise Value | $9.62B | $800.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
